BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 34571724)

  • 1. Genetic Mutations and Non-Coding RNA-Based Epigenetic Alterations Mediating the Warburg Effect in Colorectal Carcinogenesis.
    Abi Zamer B; Abumustafa W; Hamad M; Maghazachi AA; Muhammad JS
    Biology (Basel); 2021 Aug; 10(9):. PubMed ID: 34571724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Warburg meets non-coding RNAs: the emerging role of ncRNA in regulating the glucose metabolism of cancer cells.
    Yu C; Xue J; Zhu W; Jiao Y; Zhang S; Cao J
    Tumour Biol; 2015 Jan; 36(1):81-94. PubMed ID: 25431262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and epigenetic alterations of colorectal cancer.
    Hong SN
    Intest Res; 2018 Jul; 16(3):327-337. PubMed ID: 30090031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Glycolysis by Non-coding RNAs in Cancer: Switching on the Warburg Effect.
    Mirzaei H; Hamblin MR
    Mol Ther Oncolytics; 2020 Dec; 19():218-239. PubMed ID: 33251334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-coding RNAs in the reprogramming of glucose metabolism in cancer.
    Shankaraiah RC; Veronese A; Sabbioni S; Negrini M
    Cancer Lett; 2018 Apr; 419():167-174. PubMed ID: 29366802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetics of colorectal cancer.
    Migheli F; Migliore L
    Clin Genet; 2012 Apr; 81(4):312-8. PubMed ID: 22263639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging role of non-coding RNAs in glucose metabolic reprogramming and chemoresistance in colorectal cancer.
    Yan S; Wang S; Wang X; Dai W; Chu J; Cheng M; Guo Z; Xu D
    Front Oncol; 2022; 12():954329. PubMed ID: 35978828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetics of colorectal cancer: emerging circulating diagnostic and prognostic biomarkers.
    Danese E; Montagnana M
    Ann Transl Med; 2017 Jul; 5(13):279. PubMed ID: 28758105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer.
    Patnaik S; Anupriya
    Front Pharmacol; 2019; 10():588. PubMed ID: 31244652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting histone methylation for colorectal cancer.
    Huang T; Lin C; Zhong LL; Zhao L; Zhang G; Lu A; Wu J; Bian Z
    Therap Adv Gastroenterol; 2017 Jan; 10(1):114-131. PubMed ID: 28286564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer.
    Fanale D; Castiglia M; Bazan V; Russo A
    Adv Exp Med Biol; 2016; 937():207-28. PubMed ID: 27573902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic Landscape of Liquid Biopsy in Colorectal Cancer.
    Rodriguez-Casanova A; Costa-Fraga N; Bao-Caamano A; López-López R; Muinelo-Romay L; Diaz-Lagares A
    Front Cell Dev Biol; 2021; 9():622459. PubMed ID: 33614651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNAs in Colorectal Cancer: Progression and Future Directions.
    Yang Y; Junjie P; Sanjun C; Ma Y
    J Cancer; 2017; 8(16):3212-3225. PubMed ID: 29158793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncoding RNAs in the development, diagnosis, and prognosis of colorectal cancer.
    Weng M; Wu D; Yang C; Peng H; Wang G; Wang T; Li X
    Transl Res; 2017 Mar; 181():108-120. PubMed ID: 27810413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA KCNQ1OT1 promotes colorectal carcinogenesis by enhancing aerobic glycolysis via hexokinase-2.
    Chen C; Wei M; Wang C; Sun D; Liu P; Zhong X; Yu W
    Aging (Albany NY); 2020 Jun; 12(12):11685-11697. PubMed ID: 32564010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic-based therapy for colorectal cancer: Prospect and involved mechanisms.
    Rezapour S; Hosseinzadeh E; Marofi F; Hassanzadeh A
    J Cell Physiol; 2019 Nov; 234(11):19366-19383. PubMed ID: 31020647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Alterations Upstream and Downstream of p53 Signaling in Colorectal Carcinoma.
    Tomicic MT; Dawood M; Efferth T
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of the Microbiota Inhibitory Mechanism on the Warburg Effect in Colorectal Cancer Cells.
    Eslami M; Sadrifar S; Karbalaei M; Keikha M; Kobyliak NM; Yousefi B
    J Gastrointest Cancer; 2020 Sep; 51(3):738-747. PubMed ID: 31735976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of epigenetics in colorectal cancer.
    Coppedè F
    Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):935-48. PubMed ID: 24871610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirtuin 6 and metabolic genes interplay in Warburg effect in cancers.
    Al-Azzam N
    J Clin Biochem Nutr; 2020 May; 66(3):169-175. PubMed ID: 32523242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.